Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. INBS
stocks logo

INBS

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
3.33M
+304.22%
--
--
Estimates Revision
Stock Price
Go Down
down Image
-51.81%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Intelligent Bio Solutions Inc (INBS.O) is 2.13, compared to its 5-year average forward P/E of -1.41. For a more detailed relative valuation and DCF analysis to assess Intelligent Bio Solutions Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.41
Current PE
2.13
Overvalued PE
0.85
Undervalued PE
-3.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
15.12
Current PS
0.00
Overvalued PS
49.58
Undervalued PS
-19.35
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

INBS News & Events

Events Timeline

(ET)
2025-11-12
08:35:26
Intelligent Bio Solutions Announces Q1 EPS of 35c Compared to (70c) from Last Year
select
2025-11-04 (ET)
2025-11-04
08:31:37
Intelligent Bio Anticipates 32% Sequential Revenue Growth for Q1
select
2025-10-30 (ET)
2025-10-30
08:36:44
Intelligent Bio Solutions Gains 33 New Customer Accounts in Q1
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.0
09-26Newsfilter
Intelligent Bio Solutions Enhances Readiness and Shares Revised Timeline for Expected FDA 510(k) Submission and Approval

  • Clinical Studies Initiation: Intelligent Bio Solutions Inc. (INBS) is starting clinical studies to validate its Intelligent Fingerprinting Drug Screening System, aiming for FDA 510(k) clearance in the second half of 2026.

  • Global Adoption and Market Expansion: The company's drug testing technology is already in use by over 450 accounts across 24 countries, with plans to expand its commercial operations in various industries while seeking FDA clearance for broader U.S. market entry.

[object Object]
Preview
9.0
09-17Newsfilter
Intelligent Bio Solutions Updates on FDA 510(k) Clearance Progress for Intelligent Fingerprinting Drug Testing System

  • FDA Clearance Update: Intelligent Bio Solutions Inc. is in the process of obtaining FDA 510(k) clearance for its Intelligent Fingerprinting Drug Screening System, having submitted a premarket notification in December 2024 and responded to FDA inquiries in August 2025.

  • Commercial Growth and Technology Potential: The company is advancing its international business while developing a non-invasive drug screening technology that analyzes fingerprint sweat, aiming to provide rapid results for workplace drug testing.

[object Object]
Preview
7.5
08-19Newsfilter
Intelligent Bio Solutions Reports Record Monthly Sales Exceeding 12,500 Higher-Margin Cartridges in July

  • Record Sales Achievement: Intelligent Bio Solutions Inc. reported its highest-ever monthly cartridge sales in July 2025, with 519 boxes shipped, translating to over 12,500 cartridges and a 60% year-on-year increase.

  • Business Model Success: The company's fingerprint sweat-based drug testing system relies on cartridges as a high-margin consumable, contributing to a growing recurring revenue stream driven by new contracts and an expanding global installed base.

  • Contract Wins and Expansion: A significant tender win in the transportation sector has bolstered demand for consumables, and the company is actively pursuing large-scale deployment opportunities.

  • Future Growth Plans: INBS aims to leverage its installed base for ongoing cartridge sales while preparing for U.S. market expansion beyond forensic use in the latter half of 2025.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Intelligent Bio Solutions Inc (INBS) stock price today?

The current price of INBS is 0.7469 USD — it has increased 7.79 % in the last trading day.

arrow icon

What is Intelligent Bio Solutions Inc (INBS)'s business?

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

arrow icon

What is the price predicton of INBS Stock?

Wall Street analysts forecast INBS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for INBS is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Intelligent Bio Solutions Inc (INBS)'s revenue for the last quarter?

Intelligent Bio Solutions Inc revenue for the last quarter amounts to 1.11M USD, increased 27.46 % YoY.

arrow icon

What is Intelligent Bio Solutions Inc (INBS)'s earnings per share (EPS) for the last quarter?

Intelligent Bio Solutions Inc. EPS for the last quarter amounts to -0.35 USD, decreased -50.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Intelligent Bio Solutions Inc (INBS)'s fundamentals?

The market is revising No Change the revenue expectations for INBS for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -51.81%.
arrow icon

How many employees does Intelligent Bio Solutions Inc (INBS). have?

Intelligent Bio Solutions Inc (INBS) has 16 emplpoyees as of December 05 2025.

arrow icon

What is Intelligent Bio Solutions Inc (INBS) market cap?

Today INBS has the market capitalization of 7.11M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free